cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Johnson Johnson
499 own
446 watching
Current Price
$155.8
$-1.08
(-0.69%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
412,523.73M
52-Week High
52-Week High
181.03900
52-Week Low
52-Week Low
150.11000
Average Volume
Average Volume
5.57M
Dividend Yield
Dividend Yield
0.025332
P/E Ratio
P/E Ratio
24.4496
iconMarket Capitalization412,523.73M
icon52-Week High181.03900
icon52-Week Low150.11000
iconAverage Volume5.57M
iconDividend Yield0.025332
iconP/E Ratio24.4496
What does the Johnson Johnson do?
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising brand adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Read More
How much money does Johnson Johnson make?
News & Events about Johnson Johnson.
Zolmax
3 months ago
Birmingham Capital Management Co. Inc. AL cut its holdings in Johnson & Johnson (NYSE:JNJ Get Rating) by 1.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 45,548 shares of the companys stock after selling 750 shares during the period. Johnson...
Zolmax
3 months ago
Wallace Advisory Group LLC bought a new position in shares of Johnson & Johnson (NYSE:JNJ Get Rating) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 7,946 shares of the companys stock, valued at approximately $1,404,000. Johnson & Johnson accounts for 1....
Globe Newswire
3 months ago
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company ...
Globe Newswire
3 months ago
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and ...
Zolmax
5 months ago
Parallel Advisors LLC raised its holdings in Johnson & Johnson (NYSE:JNJ Get Rating) by 4.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 58,591 shares of the companys stock after purchasing an additional...
Frequently Asked Questions
Frequently Asked Questions
What is Johnson Johnson share price today?
plus_minus_icon
Can Indians buy Johnson Johnson shares?
plus_minus_icon
How can I buy Johnson Johnson shares from India?
plus_minus_icon
Can Fractional shares of Johnson Johnson be purchased?
plus_minus_icon
What are the documents required to start investing in Johnson Johnson stocks?
plus_minus_icon
What is today’s traded volume of Johnson Johnson?
plus_minus_icon
What is today’s market capitalisation of Johnson Johnson?
plus_minus_icon
What is the 52-Week High and Low Range of Johnson Johnson?
plus_minus_icon
What percentage is Johnson Johnson down from its 52-Week High?
plus_minus_icon
What percentage is Johnson Johnson up from its 52-Week Low?
plus_minus_icon
Current Price
$155.8
$-1.08
(-0.69%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Merck & Co. Inc.
Merck & Co. Inc.
$103.00
$-1.30 (-1.25 %)
General Mills, Inc.
General Mills, Inc.
$63.99
$-0.12 (-0.19 %)
General Electric Company
General Electric Company
$110.56
$-1.78 (-1.58 %)
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co.
$58.07
$-0.07 (-0.12 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Merck & Co. Inc.
Merck & Co. Inc.
$103.00
$-1.30 (-1.25 %)
General Mills, Inc.
General Mills, Inc.
$63.99
$-0.12 (-0.19 %)
General Electric Company
General Electric Company
$110.56
$-1.78 (-1.58 %)
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co.
$58.07
$-0.07 (-0.12 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00